Warning: Undefined variable $zfal in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Deprecated: str_replace(): Passing null to parameter #3 ($subject) of type array|string is deprecated in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 530
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 531
 
English Wikipedia
Nephropedia Template TP (
Twit Text
DeepDyve
Pubget Overpricing |  
lüll
Mouse models of abdominal aortic aneurysms Daugherty A; Cassis LAArterioscler Thromb Vasc Biol 2004[Mar]; 24 (3): 429-34Many mouse models of abdominal aortic aneurysms have been developed that use a diverse array of methods for producing the disease, including genetic manipulation and chemical induction. These models could provide insight into potential mechanisms in the development of this disease. Although experimental studies on abdominal aortic aneurysms (AAAs) have used a variety of mammalian and avian approaches, there is an increasing reliance on the use of mice. The models recapitulate some facets of the human disease including medial degeneration, inflammation, thrombus formation, and rupture. Most of the mouse models of AAA are evoked either by genetically defined approaches or by chemical means. The genetic approaches are spontaneous and engineered mutations. These include defects in extracellular matrix maturation, increased degradation of elastin and collagen, aberrant cholesterol homeostasis, and enhanced production of angiotensin peptides. The chemical approaches include the intraluminal infusion of elastase, periaortic incubations of calcium chloride, and subcutaneous infusion of AngII. A common feature of these models is the reduction of AAA incidence and severity by the prophylactic administration of matrix metalloproteinase (MMP) inhibitors or genetically engineered deficiencies of specific members of this proteolytic protein family. The validation of mouse models of AAAs will provide insight into the mechanisms of progression of the human disease.|*Aortic Aneurysm, Abdominal/blood/chemically induced/genetics/physiopathology/prevention & control[MESH]|*Models, Animal[MESH]|Angiotensin II/genetics/toxicity[MESH]|Animals[MESH]|Apolipoproteins E/deficiency/genetics[MESH]|Calcium Chloride/toxicity[MESH]|Cholesterol/metabolism[MESH]|Disease Models, Animal[MESH]|Extracellular Matrix Proteins/genetics/metabolism[MESH]|Female[MESH]|Genetic Engineering[MESH]|Genetic Predisposition to Disease[MESH]|Humans[MESH]|Hyperlipidemias/complications/genetics[MESH]|Matrix Metalloproteinase Inhibitors[MESH]|Matrix Metalloproteinases/deficiency/genetics/physiology[MESH]|Mice[MESH]|Mice, Knockout/*genetics[MESH]|Mice, Mutant Strains/*genetics[MESH]|Nitric Oxide Synthase Type II[MESH]|Nitric Oxide Synthase Type III[MESH]|Nitric Oxide Synthase/deficiency/genetics[MESH]|Pancreatic Elastase/toxicity[MESH]|Protease Inhibitors/therapeutic use[MESH]|Receptors, LDL/deficiency/genetics[MESH]|Renin/genetics[MESH]|Species Specificity[MESH] |
